Compounds > quinoxalines
Page last updated: 2024-08-17

quinoxalines and Optic Neuritis

quinoxalines has been researched along with Optic Neuritis in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Azuchi, Y; Guo, X; Harada, C; Harada, T; Kimura, A; Mitamura, Y; Namekata, K; Noro, T; Semba, K; Yoshida, H1
Bähr, M; Boretius, S; Diem, R; Fairless, R; Frahm, J; Gadjanski, I; Hochmeister, S; Knöferle, J; Lingor, P; Michaelis, T; Sättler, MB; Storch, MK; Sühs, KW; Williams, SK1
Lagrèze, WA1

Other Studies

3 other study(ies) available for quinoxalines and Optic Neuritis

ArticleYear
Brimonidine suppresses loss of retinal neurons and visual function in a murine model of optic neuritis.
    Neuroscience letters, 2015, Apr-10, Volume: 592

    Topics: Administration, Ophthalmic; Adrenergic alpha-2 Receptor Agonists; Animals; Brimonidine Tartrate; Female; Mice, Inbred C57BL; Nerve Growth Factors; Neuroprotective Agents; Ophthalmic Solutions; Optic Neuritis; Quinoxalines; Retinal Neurons; Up-Regulation

2015
Role of n-type voltage-dependent calcium channels in autoimmune optic neuritis.
    Annals of neurology, 2009, Volume: 66, Issue:1

    Topics: 2',3'-Cyclic-Nucleotide Phosphodiesterases; Amlodipine; Amyloid beta-Protein Precursor; Animals; Autoimmune Diseases; Calcium; Calcium Channel Blockers; Calcium Channels, N-Type; Cytokines; Disease Models, Animal; Drug Interactions; Ectodysplasins; Egtazic Acid; Excitatory Amino Acid Antagonists; Female; Glial Fibrillary Acidic Protein; Magnetic Resonance Imaging; Manganese; Myelin Proteins; Myelin-Associated Glycoprotein; Myelin-Oligodendrocyte Glycoprotein; Neoplasm Proteins; omega-Conotoxin GVIA; Optic Nerve; Optic Neuritis; Quinoxalines; Rats; RNA-Binding Proteins

2009
[Neuroprotection. Bases and possibilities of a future clinical use].
    Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 2001, Volume: 98, Issue:3

    Topics: Adrenergic alpha-Agonists; Animals; Apoptosis; Brimonidine Tartrate; Clinical Trials as Topic; Disease Models, Animal; Dopamine Agents; Eye Diseases; Forecasting; Glaucoma; Humans; Memantine; Neuroprotective Agents; Optic Neuritis; Quinoxalines; Retinal Diseases; Visual Fields

2001